In short. Growth factors measured in a laboratory dish, and why a laboratory finding is not the same thing as a result in a living face.
Key points
- Measuring what a material releases is the beginning of the reasoning, not the end of it.
- The clinical question is what reaches the tissue and what it does there, and that question is answered by clinical studies rather than by laboratory measurements.
The mechanism claimed for platelet-rich fibrin runs from a laboratory measurement to a clinical promise, and the steps in between are where it becomes an argument rather than a finding.
The laboratory finding
Growth factors associated with platelet activity have been measured released from the preparation in laboratory work, and the measurement is genuine. It establishes that the substances are present and that they are released under those conditions. It is a statement about what the material does in a dish, where the temperature, the medium and the timing are controlled, and it is a long way from a face.
The steps the finding does not cover
For the laboratory finding to become a clinical effect, several things have to happen in sequence. The substances have to reach living tissue rather than the dish. They have to arrive in a concentration that matters and stay long enough to act on cells. The cells have to respond in a way that produces a change. And the change has to accumulate into something a person can see. Each step can fail on its own, and a laboratory measurement tests none of them. That is not a criticism of the laboratory work; it is a description of what such work is for.
Release in a dish is not delivery in tissue
Measuring what a material releases is the beginning of the reasoning, not the end of it. The clinical question is what reaches the tissue and what it does there, and that question is answered by clinical studies rather than by laboratory measurements.
The fibrin network and slow release
The most plausible part of the story concerns the fibrin network, which could slow the release of what it contains and hold it in place for longer than a liquid preparation would. That reasoning is sound as a hypothesis about the material, and it is the reason the preparation was developed. What it lacks is a comparison: a study showing that this preparation produces a different clinical result from an alternative, over a period, in people. Without that, the mechanism explains why somebody thought it would work and does not establish that it does.
Where the mechanism is asked to do too much
Mechanism language is used in this subject to support claims the mechanism cannot reach: that tissue is rebuilt, that volume is restored, that skin quality improves. Each of those is an outcome claim and each needs outcome evidence. The mechanism is discussed at length in the marketing because it is the strongest part of the case, and its strength is exactly the reason the missing step goes unnoticed.
Three things the mechanism does not tell you
- Whether the substances reach the tissue in a concentration that matters.
- Whether anything a person would notice changes as a result.
- Whether this preparation does anything that another, better-defined option does not.
The mechanism is a reasonable hypothesis. It is not a result, and treating it as one is the most common error made about this treatment.
Frequently asked questions
What growth factors are involved?
Several factors associated with platelet activity have been measured released from the preparation in laboratory work. The measurements are real and they establish that the substances are present and released under those conditions. They do not establish anything about what happens when the preparation is injected into living tissue.
Why does a laboratory result not predict a clinical one?
Because several steps sit between them. The substances must reach living tissue, in a concentration that matters, remain there long enough to act, and produce a change in cells that responds. A dish measures release; it does not measure delivery, persistence or effect, and each of those can fail separately.
Does the fibrin network make the growth factors last longer?
That is the plausible part of the claim. A fibrin network could slow the release of what is inside it, and slower release is the mechanism usually described. The reasoning is reasonable and the clinical consequence of it has not been demonstrated in a comparison against anything else.
Risks & Limitations
- The preparation is made in the room and is not standardised, so two clinics offering the same named treatment are not necessarily offering the same material.
- Blood handled outside a controlled laboratory is a medium in which bacteria grow, so preparation carries a risk of infection that the source of the blood does not remove.
- The material is reabsorbed over a short period, so it does not restore volume the way a filler does.
- There is no product authorisation and no approved indication, because there is no manufactured product to authorise.
- Growth factors measured in laboratory work are a finding about the material and not a demonstrated clinical result.
When to Seek Care
- Redness, warmth, swelling or pain that is increasing rather than settling after an injection.
- Discharge from an injection site, or a fever — seek prompt clinical assessment.
- An uneven or lumpy result, or any change in the treated area that concerns you.
- Contact the service that performed the treatment, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — guidance on autologous cellular products and point-of-care preparation
- European Medicines Agency (EMA) and national regulators — guidance on blood-derived and autologous treatments
- National Medical Products Administration (NMPA, China) — regulation of blood-derived preparations and devices
- World Health Organization (WHO) — guidance on the safe preparation and handling of blood components
- Cochrane Library — systematic reviews of platelet concentrates for skin and wound indications
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.